๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP ยท Real-Time Price ยท USD
0.9500
-0.0199 (-2.05%)
At close: Nov 20, 2026, 4:00 PM EST
1.040
+0.090 (9.47%)
After-hours: Nov 20, 2026, 4:36 PM EST

Cocrystal Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.44-----
Revenue Growth
------
Gross Profit
-4.62-5.06-12.54-15.17-12.39-8.79
Operating Income
-11.51-9.02-17.88-21.16-18.14-14.22
Net Income
-11.33-8.83-17.5-17.98-38.84-14.19
Earnings Per Share
-0.77-0.78-1.72-1.86-4.77-1.93
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.877.039.8626.3537.1458.71
Total Debt
1.261.511.811.850.30.53
Net Cash (Debt)
3.625.528.0524.536.8558.17
Net Cash Growth
-41.16%-31.46%-67.13%-33.51%-36.66%79.46%
Net Cash Per Share
0.250.490.792.544.527.90

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--8.19-16.49-14.67-21.44-12.72
Capital Expenditures
--0.01-0.01-0.12-0.07-0.05
Free Cash Flow
--8.2-16.49-14.78-21.51-12.77
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-2645.98%-----
Profit Margin
-2605.29%-----
FCF Margin
------

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
42.07-----